Opioid overdose has long been a leading cause of death, especially among Americans under 50. The current “4th wave” of the epidemic—marked by potent fentanyl analogues, stimulant co-use, and contamination with substances like xylazine—makes treatment increasingly difficult. While evidence-based tools like buprenorphine, methadone, naloxone, and harm reduction remain essential, access is often blocked by insurance … Read more
Opioid overdose has long been a leading cause of death, especially among Americans under 50. The current “4th wave” of the epidemic—marked by potent fentanyl analogues, stimulant co-use, and contamination with substances like xylazine—makes treatment increasingly difficult. While evidence-based tools like buprenorphine, methadone, naloxone, and harm reduction remain essential, access is often blocked by insurance … Read more
Opioid overdose has long been a leading cause of death, especially among Americans under 50. The current “4th wave” of the epidemic—marked by potent fentanyl analogues, stimulant co-use, and contamination with substances like xylazine—makes treatment increasingly difficult. While evidence-based tools like buprenorphine, methadone, naloxone, and harm reduction remain essential, access is often blocked by insurance … Read more
Opioid overdose has long been a leading cause of death, especially among Americans under 50. The current “4th wave” of the epidemic—marked by potent fentanyl analogues, stimulant co-use, and contamination with substances like xylazine—makes treatment increasingly difficult. While evidence-based tools like buprenorphine, methadone, naloxone, and harm reduction remain essential, access is often blocked by insurance … Read more
Opioid overdose has long been a leading cause of death, especially among Americans under 50. The current “4th wave” of the epidemic—marked by potent fentanyl analogues, stimulant co-use, and contamination with substances like xylazine—makes treatment increasingly difficult. While evidence-based tools like buprenorphine, methadone, naloxone, and harm reduction remain essential, access is often blocked by insurance … Read more
Opioid overdose has long been a leading cause of death, especially among Americans under 50. The current “4th wave” of the epidemic—marked by potent fentanyl analogues, stimulant co-use, and contamination with substances like xylazine—makes treatment increasingly difficult. While evidence-based tools like buprenorphine, methadone, naloxone, and harm reduction remain essential, access is often blocked by insurance … Read more